Azurin v. Bio-Medical Applications of California, Inc.

CourtDistrict Court, D. Massachusetts
DecidedMarch 25, 2024
Docket1:23-cv-11585
StatusUnknown

This text of Azurin v. Bio-Medical Applications of California, Inc. (Azurin v. Bio-Medical Applications of California, Inc.) is published on Counsel Stack Legal Research, covering District Court, D. Massachusetts primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Azurin v. Bio-Medical Applications of California, Inc., (D. Mass. 2024).

Opinion

UNITED STATES DISTRICT COURT DISTRICT OF MASSACHUSETTS ____________________________________ ) JONATHAN AZURIN, Individually ) and for Other Similarly Situated, ) ) Plaintiffs, ) ) ) Civil Action No. 23-CV-11585-AK v. ) ) BIO-MEDICAL APPLICATIONS OF ) CALIFORNIA, INC. and FRESENIUS ) MEDICAL CARE HOLDINGS, INC. ) d/b/a FRESENIUS MEDICAL CARE ) NORTH AMERICA, ) ) Defendants. ) )

MEMORANDUM AND ORDER ON DEFENDANTS’ MOTION TO DISMISS PLAINTIFF’S CLASS ACTION COMPLAINT OR, ALTERNATIVELY, TO STAY CASE

ANGEL KELLEY, D.J. Plaintiff John Azurin, on behalf of himself and other similarly situated employees, (collectively, “Azurin” or “Plaintiffs”) bring this action against Defendants Bio-Medical Applications of California, Inc. (“BMA”) and Fresenius Medical Care Holdings, Inc. d/b/a Fresenius Medical Care North America (“Fresenius”) (collectively, “Defendants”). [Dkt. 1 (“Compl.”)]. Azurin seeks to recover unpaid wages and other damages from the Defendants. [Id.]. On August 30, 2023, Defendants filed their Motion to Dismiss the Class Action Complaint or, Alternatively, to Stay Case. [Dkt. 14]. For the following reasons, Defendants’ Motion to Dismiss [Dkt. 14] is DENIED and Azurin’s action may continue before this Court. I. BACKGROUND Unless otherwise noted, the facts are presented as alleged in the Complaint. On July 14, 2023, Plaintiffs filed suit alleging that Defendants had improperly withheld wages through a meal period deduction and through their failure to incorporate shift differentials in their overtime

calculations. [See Compl.]. Defendant Fresenius is a New York Corporation with its headquarters in Waltham Massachusetts; BMA is a wholly owned subsidiary of Fresenius. [Id. at ¶¶ 39, 41]. Fresenius owns a network of around 4,100 dialysis clinics, including a number in California. [Id. at ¶ 45]. Fresenius and BMA employed Azurin as a Registered Nurse (RN) in and around Bakersfield and West Covina, California. [Id. at ¶ 2]. Azurin alleges he regularly worked more than 40 hours a week. [Id. at ¶ 3]. Despite this, Defendants failed to pay him for all of those hours he worked. [Id. at ¶ 4]. Instead, the Defendants automatically deducted one hour a day from his work time for meal breaks even when he did not actually receive bona fide meal breaks. [Id. at ¶¶ 5, 7-8]. In addition, Defendants also required Azurin to remain on duty and perform

compensable work throughout his shifts including during the supposed meal breaks he received. [Id. at ¶ 9]. While employed, Defendants failed to pay Azurin the mandatory one hour of premium pay, at his regular rate of pay, for each day that Defendants denied them an off-duty meal period. [Id. at ¶ 86]. Defendants also paid Azurin different hourly rates, or shift differentials, based on the type of shift he worked. [Id. at ¶ 14]. However, these shift differentials were not included when Azurin regular rates of pay were calculated for the purpose of overtime. [Id. at ¶ 15]. Azurin was also not provided with accurate, itemized wage statements. [Id. at ¶ 88]. Azurin alleges that a number of other employees, who make up members of a class he seeks to represent, also had these experiences. Azurin defines the putative class of similarly situated employees as: “All hourly, non-exempt employees who worked for, or on behalf of, Fresenius through BMA in California who received (1) a meal period deduction and/or (2) shift differentials at any time during the past 4 years (“Putative Class Members”).” [Id. at 38]. Azurin brings the following

claims: Failure to Pay Overtime and Double Time Wages Pursuant to Cal. Lab. Code § 510 (Count I); Failure to Pay Earned Wages for all Hours Worked Pursuant to Cal. Lab. Code § 204 (Count II); Failure to Authorize, Permit, and/or Make Available Bone Fide Meal Periods Pursuant to Cal. Lab. Code §§ 226.7 and 512 (Count III); Failure to Provide Accurate Itemized Wage Statements Pursuant to Cal. Lab. Code § 226 (Count IV); Waiting Time Penalties Pursuant to Cal. Lab. Code §§ 201-203 (Count V); Violation of California’s Unfair Competition Law Pursuant to Cal. Bus. & Prof. Code §§ 17200 (Count VI). [Id. at ¶¶ 201-277]. Defendants bring their Motion to Dismiss [Dkt. 14] arguing that this case entirely overlaps with another putative class action case called Calderon v. Bio-Med. Applications of Mission Hills, Inc. DBA Fresenius Kidney Care Mission Hills, No. 22ST-CV-24391 (“Calderon case”). The Calderon case features virtually the same claims.1 [Dkt. 15-2 at 2]. While the 0F named Plaintiffs in both are different, the defendants in the Calderon case include Bio-Medical Applications of Mission Hills, Inc. (“BMA Mission Hills”), who is not a party to this action, and Bio-Medical Applications of California, Inc., and Fresenius management Services, Inc. d/b/a Fresenius Medical Care North America, who are the Defendants here.2 [Id. at ¶ 10]. The 1F

1 The Calderon case brings claims for Failure to Pay Minimum and Straight Time Wages (Cal. Lab. Code §§ 204, 1194, 1194.2, and 1197); Failure to Pay Overtime Wages (Cal. Lab. Code §§ 1194 and 1198); Failure to Provide Meal Periods (Cal. Lab. Code §§ 226.7, 512); Failure to Authorize and Permit Rest Periods (Cal. Lab. Code §§ 226.7); Failure to Timely Pay Final Wages at Termination (Cal. Lab. Code §§ 201-203); Failure to Provide Accurate Itemized Wage Statements (Cal. Lab. Code § 226); and Unfair Business Practices (Cal. Bus. & Prof. Code §§ 17200, et seq.). [Dkt. 15-2 at 2].

2 The Calderon complaint additionally names Does 1-10 as additional defendants who are as of yet unknown. [Dk. 15-2 at 6]. proposed class in Calderon is: “All persons who worked for any Defendant in California as an hourly-paid or non-exempt employee at any time during the period beginning March 21, 2019 and ending when notice to the Class is sent.” [Id. at ¶ 24]. Such a class is broader than, and would envelop, the proposed class in the instant case. As such, Defendants argue that this case

should be dismissed pursuant to the Colorado River doctrine, or alternatively stayed pending the resolution of the first-filed case.3 [Dkt. 15 at 1]. The Court heard argument on this matter on 2F February 22, 2024, and took the matter under advisement. [Dkt. 33]. II. DISCUSSION The Colorado River abstention doctrine “permits federal courts to decline jurisdiction in favor of parallel state litigation for reasons of ‘wise judicial administration.’” Villa Marina Yacht Sales, Inc. v. Hatteras Yachts, 915 F.2d 7, 8 (1st Cir. 1990) (quoting Colo. River Water Conservation Dist. v. U.S., 424 U.S. 800, 818 (1976)). The First Circuit has noted that this doctrine is narrow and should be used only sparingly. “Of all the abstention doctrines, it is to be approached with the most caution, with ‘[o]nly the clearest of justifications’ warranting dismissal.’” Jimenez v. Rodriguez–Pagan, 597 F.3d 18, 27 (1st Cir. 2010) (quoting Colo. River, 424 U.S. at 819). The “presence of parallel litigation in state court will not in and of itself merit abstention in federal court.” Id. “[T]here is nothing unusual about parallel litigation resolving similar controversies in both state and federal court.” Nazario-Lugo v.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

William A. Burns v. Jamie N. Watler, Etc.
931 F.2d 140 (First Circuit, 1991)
Nazario-Lugo v. Caribevision Holdings, Inc.
670 F.3d 109 (First Circuit, 2012)
Paul Revere Variable Annuity Insurance v. Thomas
66 F. Supp. 2d 217 (D. Massachusetts, 1999)
Pullman Arms Inc. v. Healey
364 F. Supp. 3d 118 (District of Columbia, 2019)
Jiménez v. Rodríguez-Pagán
597 F.3d 18 (First Circuit, 2010)
Ackerman v. Exxonmobil Corp.
734 F.3d 237 (Fourth Circuit, 2013)
Spark Energy Gas, LP v. Toxikon Corp.
864 F. Supp. 2d 210 (D. Massachusetts, 2012)
Bethlehem Contracting Co. v. Lehrer/McGovern, Inc.
800 F.2d 325 (Second Circuit, 1986)
Glassie v. Doucette
55 F.4th 58 (First Circuit, 2022)

Cite This Page — Counsel Stack

Bluebook (online)
Azurin v. Bio-Medical Applications of California, Inc., Counsel Stack Legal Research, https://law.counselstack.com/opinion/azurin-v-bio-medical-applications-of-california-inc-mad-2024.